Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Lifesci Capital issued their Q2 2024 EPS estimates for Enliven Therapeutics in a report released on Wednesday, May 15th. Lifesci Capital analyst S. Slutsky anticipates that the company will post earnings per share of ($0.51) for the quarter. The consensus estimate for Enliven Therapeutics’ current full-year earnings […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) insider Joseph P. Lyssikatos sold 12,000 shares of the company’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $17.92, for a total value of $215,040.00. The transaction was disclosed in a legal filing with the Securities […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) insider Joseph P. Lyssikatos sold 12,000 shares of the firm’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $18.60, for a total value of $223,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, […]
Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 6.2% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s share price was down 4.5% during trading on Friday . The company traded as low as $15.59 and last traded at $15.61. Approximately 22,436 shares changed hands during trading, a decline of 80% from the average daily volume of 112,286 shares. The stock had previously closed at […]
Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) dropped 2.2% during mid-day trading on Tuesday . The stock traded as low as $14.18 and last traded at $14.52. Approximately 20,237 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 134,168 shares. The stock had previously closed […]